New Blood Test May Help Identify Alzheimer’s Disease
A long-term study supports earlier suggestions that testing the blood for levels of a specific protein could be a noninvasive method to follow the advancement of Alzheimer’s illness.
The protein is called neurofilament light. It spills out of harmed and dying bucket nerve cells, into the cerebrospinal liquid and after that move from that point into the circulation system.
UPI reports that a newfound development in blood testing may help grow new medicines for Alzheimer’s disease.
According to research published Wednesday in the journal Alzheimer’s & Dementia, scientists have found that the number of fatty molecules found in the blood may contribute to the build-up of the amyloid peptide in the brain.
Amyloid peptide then converts into toxic plaques in the brain that contributes to damaging nerve cells.
This can cause plaque build-up to begin many years before any symptoms of Alzheimer show
